MGC Pharmaceuticals Limited

MGC Pharmaceuticals Limitedverified

MXC.L

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in Australia, Israel, and Slovenia. The company's principal product candidates include CimetrA, which is in phase III clinical trial for early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for symptomatic relief of Dementia. It has research and development agreement with Royal Melbourne Institute of Technology and the University of Notre Dame; and collaboration agreement with the Slovenian National Institute of Biology and Neurosurgery Department at the University Medical Centre. The company was formerly known as Erin R...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-02-09

Stock Exchange

LSE

Ticker

MXC.L

The Enterprise Value as of December 2025 (TTM) for MGC Pharmaceuticals Limited (MXC.L) is 27.93M

According to MGC Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 27.93M. This represents a change of -90.78% compared to the average of 302.86M of the last 4 quarters.

MGC Pharmaceuticals Limited (MXC.L) Historical Enterprise Value (quarterly & annually)

How has MXC.L Enterprise Value performed in the past?

The mean historical Enterprise Value of MGC Pharmaceuticals Limited over the last ten years is 35.02M. The current 27.93M Enterprise Value has changed 7.88% with respect to the historical average. Over the past ten years (40 quarters), MXC.L's Enterprise Value was at its highest in in the June 2007 quarter at 17.21B. The Enterprise Value was at its lowest in in the June 2006 quarter at -272311.00.

Quarterly (TTM)
Annual

Average

35.02M

Median

30.39M

Minimum

1.84M

Maximum

71.11M

MGC Pharmaceuticals Limited (MXC.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MGC Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 285.02%

Maximum Annual Enterprise Value = 71.11M

Minimum Annual Increase = -99.91%

Minimum Annual Enterprise Value = 1.84M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202324.25M-44.28%
202243.52M-38.79%
202171.11M157.02%
202027.67M-53.35%
201959.30M-8.02%
201864.48M94.75%
201733.11M67.58%
201619.76M285.02%
20155.13M178.97%
20141.84M-99.91%

MGC Pharmaceuticals Limited (MXC.L) Average Enterprise Value

How has MXC.L Enterprise Value performed in the past?

The current Enterprise Value of MGC Pharmaceuticals Limited (MXC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

46.29M

5-year avg

45.17M

10-year avg

35.02M

MGC Pharmaceuticals Limited (MXC.L) Enterprise Value vs. Peers

How is MXC.L’s Enterprise Value compared to its peers?

MGC Pharmaceuticals Limited’s Enterprise Value is greater than Celadon Pharmaceuticals Plc (12.68M), less than Advanced Oncotherapy plc (58.59M), greater than Induction Healthcare Group PLC (5.52M), greater than BiVictriX Therapeutics Plc (5.24M), greater than Argent BioPharma Limited (8.76M), greater than Synairgen plc (1.06M), greater than NetScientific plc (17.16M), greater than Cambridge Nutritional Sciences plc (121.04K), greater than Belluscura plc (3.30M), greater than Hellenic Dynamics Plc (-4313.00),

Build a custom stock screener for MGC Pharmaceuticals Limited (MXC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MGC Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MGC Pharmaceuticals Limited (MXC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MGC Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is MGC Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for MGC Pharmaceuticals Limited (MXC.L)?

What is the 3-year average Enterprise Value for MGC Pharmaceuticals Limited (MXC.L)?

What is the 5-year average Enterprise Value for MGC Pharmaceuticals Limited (MXC.L)?

How does the current Enterprise Value for MGC Pharmaceuticals Limited (MXC.L) compare to its historical average?